Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

BPMC Blueprint Medicines Corporation

88,35

1,15 (1,32%)

Após o horário de negociação

Última atualização: 19:30:00

Atrasado em 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/20/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

08/21/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Lonnel Coats

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Blueprint Medicines (NASDAQ:BPMC)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025

Click aqui para mais gráficos Blueprint Medicines.

Blueprint Medicines (NASDAQ:BPMC)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025

Click aqui para mais gráficos Blueprint Medicines.

Notícias Blueprint Medicines Corporation

Form 4 - Statement of changes in beneficial ownership of securities
Sexta, 20 de Dezembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Sexta, 20 de Dezembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Quinta, 19 de Dezembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Form 8-K - Current report
Quarta, 18 de Dezembro de 2024 (2 semanas atrás) • Edgar (US Regulatory)

Blueprint Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Quarta, 18 de Dezembro de 2024 (2 semanas atrás) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Segunda, 16 de Dezembro de 2024 (3 semanas atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Quinta, 12 de Dezembro de 2024 (3 semanas atrás) • Edgar (US Regulatory)

Blueprint Medicines' Continued Leadership in Redefining the Standard of Care in Systemic Mastocytosis Highlighted at 2024 ASH Annual Meeting
Sábado, 7 de Dezembro de 2024 (4 semanas atrás) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Terça, 3 de Dezembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Segunda, 2 de Dezembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Sexta, 29 de Novembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Quarta, 27 de Novembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Mais Notícias de Blueprint Medicines Corporation

Índice Bovespa

Automob Participacoes ON

Fictor Alimentos ON

Ambipar Participacoes e ... ON

PÃO DE AÇUCAR ON

Aeris Industria E Comerc... ON

MAGAZINE LUIZA ON

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições